9 WORLD GASTROENTEROLOGY NEWS JANUARY 2015 Editorial | Expert Point of View | Gastro 2015: AGW/WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events Mphahlele MJ. Impact of HIV co-infection on hepatitis B prevention and control: a view from Sub-Sa-haran Africa. South Afr J Epidemiol Infect 2008: 23(1): 14-18. Matthews PC, Gerettic AM, Gouldera PJR, Klenermana P. Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa. J Clin Virol 2014; 61: 20-33. Sangare L, Sombie R, Combassere AW et al. Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull Soc Pathol Exot 2009; 102: 226–229. Polis CB, Shah SN, Johnson KE and Gupta A. Impact of Maternal HIV Coinfection on the Vertical Transmission of Hepatitis C Virus: A Meta-analysis. Clin Infect Dis 2007; 44(8): 1123-1131. Njouom R, Pasquier C, Ayouba A et al. Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg 2005; 73: 460-466. Kramvis A and Kew M. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Research 2007; 37: S9-S19. Mayaphi SH, Roussow TM,Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. South Afr Med J 2012; 102:157–162. Kew MC. Hepatocellular carcinoma in African Blacks: recent progress in etiology and pathogenesis. World J Hepatol 2010; 2: 65-73. Thio CL, Seaberg EC, Skolasky R, Jr. et al. HIV-1, hepatitis B virus, and risk of liver-related mortal-ity in the Multicenter Cohort Study (MACS). Lancet 2002; 360 (9349):1921-1926. Falade-Nwulia O, Seaberg EC, Rinaldo CR et al. Comparative Risk of Liver-Related Mortality from Chronic Hepatitis B Versus Chronic Hepatitis C Virus Infec-tion. Clinical Infectious Diseases 2012; 55(4):507-513. Dore GJ, Soriano V, Rockstroh J et al. Frequent hepatitis B virus (HBV) rebound among HIV- HBV coin-fected patients following antiret-roviral therapy interruption in the SMART study. AIDS 2010; 24(6): 857–865. Idoko J, Seema Meloni, Muazu M et al, Impact of Hepatitis B Virus Infection on Human Immunodefi-ciency Virus Response to Antiret-roviral Therapy in Nigeria. Clin Infect Dis 2009; 49:1268-1273. Price H, Dunn D, Pillay D et al. Sup-pression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta- Analysis. PLoS One 2013; 8(7): e68152. Tuma P, Medrano J, Resino S et al. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy. Antiviral Therapy 2010; 15: 881-886. Sulkowski MS, Naggie S, Lalezari J, et al. Sofosbuvir and ribavirin for hepatitis C in patients with HIV co-infection. JAMA 2014; 312:353-361.
ewgn-vol19-issue4-FINAL
To see the actual publication please follow the link above